DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Administration of zonisamide in three cases of dementia with Lewy bodies.

Author(s): Odawara T, Shiozaki K, Togo T, Hirayasu Y

Affiliation(s): Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan. odawara@yokohama-cu.ac.jp

Publication date & source: 2010-06, Psychiatry Clin Neurosci., 64(3):327-9. Epub 2010 Apr 8.

Publication type: Case Reports

Zonisamide (ZNS) add-on administration was used to treat parkinsonian symptoms in three cases of dementia with Lewy bodies (DLB). ZNS was added after doses of the anti-Parkinson's disease drugs were fixed for at least 4 weeks. A total of 25 mg of ZNS produced mild-moderate improvement of parkinsonian symptoms in two cases, but it did not affect the cognitive functions and behavioral or psychological symptoms. Caregiver burdens were decreased in two cases. Although dizziness and drowsiness were detected, these were improved by decreasing the dose. ZNS may be useful for the treatment of motor symptoms in DLB patients.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017